Nalaganje...
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the pleural surface associated with asbestos exposure. The median survival of MPM patients is a mere 8–14 months, and there are few biomarkers and no cure available. It is hoped that, eventually, the incidence of MPM will drop and...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6992646/ https://ncbi.nlm.nih.gov/pubmed/32039010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01519 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|